Metabolism of the peptide boronic acid proteasome inhibitor bortezomib (VELCADE™) in multiple species

被引：0
|
作者：
LaButti, J [1 ]
Pekol, T [1 ]
Wang, RH [1 ]
Hsieh, F [1 ]
Daniels, JS [1 ]
Nix, D [1 ]
Gan, LS [1 ]
Miwa, G [1 ]
机构：
[1] Millennium Pharmaceut Inc, Drug Metab & Pharmacokinet, Drug Safety & Disposit, Cambridge, MA 02139 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
82
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [1] Mechanistic investigations into the protein and glutathione mediated deboronation of the peptide boronic acid proteasome inhibitor bortezomib (VELCADE™)
    Daniels, JS
    LaButti, J
    Chavan, A
    Huang, R
    Parsons, I
    Gan, LS
    Miwa, G
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 44 - 44
  • [2] Pharmacokinetics of the proteasome inhibitor bortezomib (VELCADE™) in male cynomolgus monkeys.
    Nix, D
    Milton, M
    Pligavko, C
    Nagaraja, N
    Huang, R
    Miwa, G
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6263S - 6263S
  • [3] Radiation sensitization of human cervical cancer by proteasome inhibitor Velcade (Bortezomib)
    Kamer, S.
    Ren, Q.
    Sui, Y. P.
    Kari, C.
    Rodeck, U.
    Dicker, A. P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S396 - S396
  • [4] Pharmacokinetics and tissue distribution of the proteasome inhibitor bortezomib (VELCADE™) in rat and monkey
    Nix, D
    Press, R
    Wehrman, T
    Schenkein, DP
    [J]. BLOOD, 2002, 100 (11) : 224B - 224B
  • [5] Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: Contributions from reactive oxygen species in this novel cytochrome P450 reaction
    Labutti, J
    Parsons, I
    Huang, R
    Miwa, G
    Gan, LS
    Daniels, JS
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (04) : 539 - 546
  • [6] The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer
    Thaler, Sonja
    Thiede, Gitta
    Hengstler, Jan G.
    Schad, Arno
    Schmidt, Marcus
    Sleeman, Jonathan P.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (03) : 686 - 697
  • [7] Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome
    Groll, M
    Berkers, CR
    Ploegh, HL
    Ovaa, H
    [J]. STRUCTURE, 2006, 14 (03) : 451 - 456
  • [8] The effect of proteasome inhibitor with Bortezomib (Velcade™) in B-cell lymphoma cell lines
    Strauss, SJ
    Lui, W
    Schenkein, D
    Shringarpure, R
    Anderson, K
    Lister, TA
    Joel, SP
    [J]. BLOOD, 2003, 102 (11) : 903A - 903A
  • [9] A review of the proteasome inhibitor bortezomib in multiple myeloma
    Richardson, PG
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) : 1321 - 1331
  • [10] Proteasome inhibitor bortezomib for the treatment of multiple myeloma
    M Cavo
    [J]. Leukemia, 2006, 20 : 1341 - 1352
12345